[1]张镭 商永光 郭冬杰 张翠翠 邓昂 唐崑 陆进.应用美国用药安全自我测评量表改进用药安全[J].中国卫生质量管理,2020,27(03):079-82.
　ZHANG Lei,SHANG Yongguang,GUO Dongjie,et al.Using the American Medication Safety Self-Assessment Scale to Improve Medication Safety[J].Chinese Health Quality Management,2020,27(03):079-82.
点击复制

应用美国用药安全自我测评量表改进用药安全
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第27卷
期数:
2020年03期
页码:
079-82
栏目:
患者安全
出版日期:
2020-05-28

文章信息/Info

Title:
Using the American Medication Safety Self-Assessment Scale to Improve Medication Safety
作者:
张镭 商永光 郭冬杰 张翠翠 邓昂 唐崑 陆进
中日友好医院
Author(s):
ZHANG Lei; SHANG Yongguang; GUO Dongjie; et al
China-Japan Friendship Hospital
关键词:
用药安全; 自我测评; 患者安全; 风险管理
Keywords:
Medication Safety;  Self-Assessment;  Patient Safety;  Risk Management
分类号:
R197.323；R952
文献标志码:
B
摘要:
目的评估用药安全问题，改进用药安全。方法应用美国用药安全自我测评量表（2000版），开展用药安全自我测评，发现用药安全问题，制定改进措施，降低用药安全风险。结果通过改进薄弱环节，相比2010年测评结果，2018年测评总得分权重比由56%提升至73%，19项核心特征得分权重比不同程度提高（3.1%~120.0%）。结论该用药安全自我测评量表可在改进患者用药安全方面发挥重要作用。
Abstract:
ObjectiveTo evaluate medication safety issues and improve medication safety.MethodsThe American Medication Safety Self-Assessment for Hospitals scale (version 2000) was used to carry out medication safety self-assessment, discover drug safety problems, formulate improvement measures, and reduce drug safety risks.ResultsBy improving the weak links, the weighted ratio of the total score in the 2018 evaluation increased from 56% to 73% compared with the 2010 evaluation results, and the weighted ratio of the score of the 19 core characteristics increased to different degrees (3.1%~120.0%).Conclusion The Medication Safety Self-Assessment for Hospitals can play an important role in improving the medication safety of patients.

参考文献/References:

［1］Institute of Medicine.To Err Is Human: Building a Safer Health System. Committee on Quality of Health Care in American［M］. Washington, DC: National Academy Press, 1999.

相似文献/References:

[1]侯杰 王欣 董军.静脉用药安全调配闭环管理的设计与实现[J].中国卫生质量管理,2017,24(03):007.[doi:10.13912/j.cnki.chqm.2017.24.3.03]
[2]姚丽丽 李跃荣 赵庆华 肖明朝.1例用药近似错误事件的根因分析[J].中国卫生质量管理,2020,27(01):086.[doi:10.13912/j.cnki.chqm.2020.27.1.22]
[3]钟林涛李朋梅张镭芦宏凯孙阳.患者安全目标：确保用药与用血安全[J].中国卫生质量管理,2020,27(06):005.[doi:10.13912/j.cnki.chqm.2020.27.6.02 ]
　ZHONG Lintao,LI Pengmei,ZHANG Lei,et al.Patient Safety Goal:To Ensure the Safety of Medication and Blood Use[J].Chinese Health Quality Management,2020,27(03):005.[doi:10.13912/j.cnki.chqm.2020.27.6.02 ]
[4]何芳王富兰谢莉玲 肖明朝凌舒娅.基于TeamSTEPPS的两例胰岛素用药错误原因分析及改进[J].中国卫生质量管理,2022,29(07):071.[doi:10.13912/j.cnki.chqm.2022.29.7.18 ]
　HE Fang,WANG Fulan,XIE Liling.Root Cause Analysis and Improvement of Two Cases of Incorrect Dosage of Insulin Based on TeamSTEPPS[J].Chinese Health Quality Management,2022,29(03):071.[doi:10.13912/j.cnki.chqm.2022.29.7.18 ]
[5]杨芹李凤婷王旭梅曹旺迟巍.防范儿童住院患者给药错误的最佳证据总结[J].中国卫生质量管理,2024,31(01):053.[doi:10.13912/j.cnki.chqm.2024.31.1.12]
　YANG Qin,LI Fengting,WANG Xumei.Best Evidence on Prevention of Drug Administration Errors in Pediatric Inpatients[J].Chinese Health Quality Management,2024,31(03):053.[doi:10.13912/j.cnki.chqm.2024.31.1.12]
[6]尹姣 卫攀 薛淑敏 史敏 高欢筱 王娟 张明明 彭阿丽.住院患者静脉输注血管活性药物风险管理优化研究[J].中国卫生质量管理,2024,31(09):015.[doi:10.13912/j.cnki.chqm.2024.31.9.04]
　YIN Jiao,WEI Pan,XUE Shumin.Optimization of Risk Management for Inpatient Intravenous Infusion of Vasoactive Drugs[J].Chinese Health Quality Management,2024,31(03):015.[doi:10.13912/j.cnki.chqm.2024.31.9.04]

更新日期/Last Update: 2020-05-28